Corcept Therapeutics Incorporated (CORT) valuation · P/E 245, rev $761.4M
Corcept Therapeutics Incorporated (CORT) P/E 245, rev $761.4M.
| Metric | Value |
|---|---|
| P/E | 245 |
| Market cap | $7.46B |
| Revenue | $761.4M |
| P/S | 9.8 |
CORT valuation FAQ
What is CORT's P/E ratio?
Corcept Therapeutics Incorporated (CORT) trailing P/E is 245 on the latest cached fundamentals snapshot.
What is CORT's market cap?
Corcept Therapeutics Incorporated (CORT) market cap is $7.46B on the latest cached fundamentals snapshot.
What is CORT's latest revenue?
Latest cached Corcept Therapeutics Incorporated (CORT) revenue was $761.4M. Statements: https://lician.com/financials/cort
What is CORT's price-to-sales ratio?
Corcept Therapeutics Incorporated (CORT) price-to-sales (P/S) is 9.8, cached market cap $7.46B divided by revenue $761.4M.
How many CORT valuation scalars are listed on this page?
This page lists 4 cached valuation scalars for Corcept Therapeutics Incorporated (CORT): P/E, Market cap, Revenue, and P/S.
Where is CORT valuation listed?
Cached valuation multiples for Corcept Therapeutics Incorporated (CORT) are listed at https://lician.com/valuation/cort.
Not investment advice. Cached rows, not a live tape.